162.81
Overview
News
Price History
Option Chain
Financials
Why BCPC Down?
Discussions
Forecast
Stock Split
Dividend History
Balchem Corp stock is traded at $162.81, with a volume of 129.73K.
It is up +1.12% in the last 24 hours and down -3.82% over the past month.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
See More
Previous Close:
$161.00
Open:
$161.58
24h Volume:
129.73K
Relative Volume:
0.58
Market Cap:
$5.23B
Revenue:
$1.06B
Net Income/Loss:
$158.08M
P/E Ratio:
33.44
EPS:
4.8687
Net Cash Flow:
$175.98M
1W Performance:
-0.33%
1M Performance:
-3.82%
6M Performance:
-2.82%
1Y Performance:
+9.12%
Balchem Corp Stock (BCPC) Company Profile
Name
Balchem Corp
Sector
Industry
Phone
(845) 326-5600
Address
5 PARAGON DRIVE, MONTVALE, NY
Compare BCPC vs LIN, SHW, ECL, APD, SQM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BCPC
Balchem Corp
|
162.81 | 5.23B | 1.06B | 158.08M | 175.98M | 4.8687 |
|
LIN
Linde plc Ordinary Share
|
512.28 | 236.85B | 34.66B | 7.25B | 5.10B | 15.07 |
|
SHW
Sherwin Williams Co
|
317.51 | 78.31B | 23.94B | 2.60B | 2.91B | 10.42 |
|
ECL
Ecolab Inc
|
268.75 | 75.64B | 16.45B | 2.12B | 1.87B | 7.3955 |
|
APD
Air Products Chemicals Inc
|
297.87 | 66.33B | 12.46B | 2.16B | -1.25B | 9.454 |
|
SQM
Sociedad Quimica Y Minera De Chile Sa Adr
|
68.73 | 19.63B | 5.29B | 902.58M | 1.08B | 2.8447 |
Balchem Corp Stock (BCPC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-22-22 | Upgrade | Sidoti | Neutral → Buy |
| Nov-29-21 | Downgrade | Sidoti | Buy → Neutral |
| Aug-02-21 | Downgrade | Stephens | Overweight → Equal-Weight |
| Feb-22-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-04-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-10-20 | Initiated | Stephens | Equal-Weight |
| Feb-24-20 | Reiterated | H.C. Wainwright | Buy |
| May-06-19 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-21-19 | Initiated | Seaport Global Securities | Neutral |
| Nov-06-18 | Upgrade | Pivotal Research Group | Hold → Buy |
| Oct-16-18 | Upgrade | Sidoti | Neutral → Buy |
| Sep-25-18 | Initiated | H.C. Wainwright | Buy |
| Aug-03-18 | Reiterated | Pivotal Research Group | Hold |
| May-07-18 | Upgrade | Pivotal Research Group | Sell → Hold |
| Nov-04-16 | Downgrade | Pivotal Research Group | Hold → Sell |
| Mar-08-16 | Downgrade | Sidoti | Buy → Neutral |
| Feb-02-16 | Upgrade | Sidoti | Neutral → Buy |
| Apr-02-15 | Initiated | Singular Research | Buy |
| Jul-28-10 | Initiated | DA Davidson | Neutral |
View All
Balchem Corp Stock (BCPC) Latest News
BCPC|Balchem Corp|Price:162.810|Chg%:+1.810 - TradingKey
Vitamin K2 Market Projected to Reach $339.9 million by 2031 | Top Companies are Gnosis by Lesaffre (France) and Balchem Corp (US) - WKOW
Balchem Corporation (BCPC) Stock Forecasts - Yahoo Finance
Balchem earnings up next: Can specialty ingredients sustain growth? By Investing.com - Investing.com Canada
Balchem earnings up next: Can specialty ingredients sustain growth? - Investing.com
Enterprise value to EBIT forward of Balchem Corp – BX:BL9B - TradingView
BL9B Forecast — Price Target — Prediction for 2027 - TradingView
Balchem Corporation Schedules Second Quarter 2026 Earnings Conference Call - Quiver Quantitative
Balchem to Publish Q2 Results Before Markets Open July 31 - Stock Titan
Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026 - Sahm
Encapsulated Essential Oils for Feed Market Global Report 2026 Examines Growth Opportunities, Competitive Trends and Global Forecasts - GlobeNewswire Inc.
Balchem Corp (NASDAQ:BCPC) Shines as a Quality Stock with Superior Capital Efficiency - ChartMill
Is Balchem (BCPC) Undervalued After Its Russell Value Index Additions? - Sahm
ETFs Investing in Balchem Corp Stocks - TradingView
Balchem Corp (BCPC) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
How Balchem’s Broad Russell Value Index Additions Will Impact Balchem (BCPC) Investors - simplywall.st
Price to sales forward of Balchem Corp – BMV:BCPC - TradingView
Balchem Corp (BCPC) Gains 1.18% as Shares Hold Above Key Support ZonePrice Momentum Stocks - dars.gov.et
Enterprise value to revenue forward of Balchem Corp – BMV:BCPC - TradingView
Price to earnings forward of Balchem Corp – BMV:BCPC - TradingView
Enterprise value to EBITDA forward of Balchem Corp – BMV:BCPC - TradingView
Enterprise value to EBIT forward of Balchem Corp – BMV:BCPC - TradingView
Balchem Corp Actuals & Estimates (HAM:BL9B) - TradingView
Balchem Corp Actuals & Estimates (NASDAQ:BCPC) - TradingView
Balchem Corp Actuals & Estimates (BX:BL9B) - TradingView
Balchem Corp (BCPC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Balchem sends CEO, CFO to CJS Securities conference July 9 - Stock Titan
Balchem Corp Actuals & Estimates (LSX:905650) - TradingView
905650 Forecast — Price Target — Prediction for 2027 - TradingView
Balchem (BCPC) Could Be 11% Undervalued As Growth Expectations Build - Sahm
Balchem Corp (BCPC) Institutional Confidence - TradingKey
Balchem Corp (BCPC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Balchem shareholders elect directors and approve auditor at annual meeting - Investing.com
Balchem (BCPC) investors reelect directors, approve auditor and executive pay - Stock Titan
Balchem Corp (BCPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Balchem Corp (BCPC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Balchem Corp (BCPC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Balchem Corp Annual Shareholders Meeting Transcript - GuruFocus
BCPC Stock Price, Quote & Chart - ChartMill
Balchem Corp (BCPC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Balchem Corp (BCPC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Balchem Corp (BCPC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Balchem Corporation Q1 2026 Earnings: EPS Miss Despite Strong Operational PerformanceFinancial Summary - newsline.com
Balchem Corp (NASDAQ:BCPC) Passes Caviar Cruise Quality Screen with 33% ROIC and Minimal Debt - ChartMill
Balchem Corporation (BCPC) Q1 2026 Earnings: EPS Misses Estimates, Shares Decline 2.2%Operating Income Trends - newsline.com
Balchem to present at Wells Fargo Industrials Conference on June 10, 2026 - Pluang
Health-nutrition ingredient maker Balchem heads to Wells Fargo industrials event - Stock Titan
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026 - Yahoo Finance
Balchem Q1 2026 Earnings: EPS Misses Estimates Amid Modest Stock GainRevenue Surprise History - newsline.com
Are Options Traders Betting on a Big Move in Balchem Stock? - Yahoo Finance
Earnings call transcript: Balchem’s Q1 2026 earnings beat expectations - Investing.com
Balchem Corp Stock (BCPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Balchem Corp Stock (BCPC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Fischer David B | Director |
Dec 03 '25 |
Sale |
153.97 |
8,000 |
1,231,748 |
7,989 |
| van Gunsteren Job Leonard | SVP and GM, Specialty Products |
Dec 04 '25 |
Option Exercise |
60.85 |
6,000 |
365,100 |
15,446 |
| van Gunsteren Job Leonard | SVP and GM, Specialty Products |
Dec 04 '25 |
Sale |
153.29 |
6,000 |
919,723 |
9,446 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):